User login
Article Type
              
          Changed
              Fri, 03/15/2019 - 12:32
           Recent trials advance axial spondyloarthritis therapy. Newer antihyperglycemic drugs have distinctive cardiovascular, kidney benefits. And doctors’ prior authorization burden is increasing.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify
Publications
          Topics
          
      Sections
          
       Recent trials advance axial spondyloarthritis therapy. Newer antihyperglycemic drugs have distinctive cardiovascular, kidney benefits. And doctors’ prior authorization burden is increasing.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify
 Recent trials advance axial spondyloarthritis therapy. Newer antihyperglycemic drugs have distinctive cardiovascular, kidney benefits. And doctors’ prior authorization burden is increasing.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify
Publications
          Publications
          Topics
          
      Article Type
              
          Sections
          
      Disallow All Ads
              
          Content Gating
              No Gating (article Unlocked/Free)
          Alternative CME
              
          Disqus Comments
              Default
          Consolidated Pubs: Do Not Show Source Publication Logo
              
          Use ProPublica
              
          